Vardenafil (Levitra/Staxyn) Cost in Kentucky 2026

What Vardenafil Actually Costs in Kentucky Right Now

Generic vardenafil runs about $120 per month at Kentucky retail pharmacies when you pay cash, while branded Levitra carries a list price near $350 per month. Brand Staxyn (vardenafil orally disintegrating tablet) sits in the same price range as Levitra. These figures are 2026 averages across Louisville, Lexington, Bowling Green, and smaller Kentucky markets.

Brand Versus Generic: The Price Gap

Bayer's Levitra patent expired in the United States, and multiple generic manufacturers entered the market. That competition drove generic vardenafil prices down sharply. Pfizer's sildenafil (Viagra) went through an identical trajectory after its 2017 generic entry, and vardenafil followed the same pattern. The FDA's Orange Book lists all currently approved generic vardenafil products.

Paying cash for the generic instead of the brand saves most Kentucky patients $200, $230 per month, or roughly $2,400, $2,760 per year, without any coupon or assistance program.

Per-Tablet Breakdown

A 30-tablet supply of generic vardenafil 10 mg at a Louisville Walgreens or Kroger pharmacy runs roughly $4.00 per tablet on a GoodRx-style discount card. Independent pharmacies in eastern Kentucky sometimes price lower, near $3.20 per tablet, because their overhead is smaller. Bayer's branded Levitra, by contrast, can exceed $11 per tablet at list price. FDA prescribing information for vardenafil (Levitra) confirms the 5 mg, 10 mg, and 20 mg tablet strengths available.

How Dose Strength Affects Price

Higher-strength tablets (20 mg) sometimes cost the same absolute dollar amount per tablet as the 10 mg version, which means patients who split a 20 mg tablet under physician supervision may cut per-dose cost in half. Tablet splitting is only appropriate when your prescribing clinician explicitly approves it and when the tablet is not the orally disintegrating Staxyn formulation, which must not be split or chewed.

Kentucky Medicaid Coverage for Vardenafil

Kentucky Medicaid does not cover vardenafil or any PDE5 inhibitor prescribed specifically for erectile dysfunction. This exclusion applies to both fee-for-service Kentucky Medicaid and the managed care organizations (Aetna Better Health of Kentucky, Humana CareSource, Molina Healthcare of Kentucky, United Healthcare Community Plan of Kentucky) that administer most Medicaid benefits in the state.

Why the Exclusion Exists

Federal Medicaid law (42 U.S.C. § 1396r-8) explicitly permits states to exclude drugs used for "sexual or erectile dysfunction" from their formularies unless the drug is used for a non-excluded condition. The Centers for Medicare and Medicaid Services has published guidance on this exclusion. Kentucky exercises that option. Only a small number of states have chosen to cover PDE5 inhibitors for ED through Medicaid, and Kentucky is not among them.

Exceptions: Pulmonary Arterial Hypertension

Vardenafil is not FDA-approved for pulmonary arterial hypertension (PAH), but sildenafil and tadalafil are. If a Kentucky Medicaid patient has PAH and a physician prescribes an approved PAH agent, that is a separate clinical scenario with different coverage rules. Vardenafil for ED specifically remains excluded.

Medicare Part D in Kentucky

Medicare Part D plans are also prohibited from covering drugs "used for the treatment of erectile dysfunction" under 42 U.S.C. § 1395w-102(e)(2)(A). Kentucky residents on Medicare should not expect Part D coverage for vardenafil for ED. CMS has outlined this Part D exclusion category in its Part D formulary guidance.

Is Compounded Vardenafil Legal in Kentucky?

Yes. Licensed 503A compounding pharmacies in Kentucky may legally compound vardenafil for individual patients when a valid patient-specific prescription exists. This is the same legal framework that governs most compounding pharmacies across the United States under the Drug Quality and Security Act of 2013.

What 503A Means in Practice

A 503A pharmacy compounds drugs for specific, identified patients based on a prescription from a licensed prescriber. The pharmacy does not manufacture large batches for general sale. Kentucky's Board of Pharmacy licenses and inspects these facilities, and the FDA retains oversight authority for interstate shipments. FDA's guidance on 503A compounding pharmacies spells out the conditions under which compounding is permitted.

Compounded vardenafil is not FDA-approved as a finished drug product, meaning it has not gone through the same clinical trial process as branded Levitra. Potency, stability, and sterility of the compounded product depend entirely on the individual pharmacy's quality controls.

Cost Advantage of Compounded Vardenafil

Compounded vardenafil from a 503A pharmacy may cost significantly less than retail generic vardenafil, particularly when dispensed through telehealth platforms that have negotiated pharmacy partnerships. Some telehealth providers bundle the cost of the medication into a subscription fee. Patients should verify that any compounding pharmacy filling their prescription holds an active Kentucky Board of Pharmacy license or, for out-of-state pharmacies shipping into Kentucky, an active nonresident pharmacy license recognized by Kentucky.

What 503B Facilities Cannot Do Here

503B outsourcing facilities produce larger batches without patient-specific prescriptions, but they are prohibited from compounding copies of commercially available drugs except in narrow shortage situations. Because generic vardenafil is commercially available and not on the FDA drug shortage list, 503B facilities generally may not compound it for routine ED prescriptions. FDA's 503B outsourcing facility page lists registered facilities and their permitted activities.

Insurance Coverage for Vardenafil in Kentucky

Most private insurance plans in Kentucky exclude or heavily restrict PDE5 inhibitors for ED. The situation varies by employer plan design, and some plans do offer partial coverage.

Employer-Sponsored Plans

Large Kentucky employers, including state government employees covered by the Kentucky Employees Health Plan (KEHP), set their own formulary rules within federal law. KEHP's standard formularies have historically excluded vardenafil for ED, though employees should verify current plan documents annually during open enrollment. Some private employer plans in Louisville's larger corporate sector do cover generic vardenafil at the generic tier copay, which may be $30, $50 per month rather than the full cash price.

How to Check Your Plan

The fastest way to confirm coverage is to call the member services number on your insurance card and ask specifically: "Is generic vardenafil covered on my formulary for erectile dysfunction, and what is my cost-sharing at a Kentucky in-network pharmacy?" Request the tier level and any quantity limits (many plans cap ED medications at six to eight tablets per month even when coverage exists). The ACA's essential health benefits framework does not mandate ED drug coverage, so insurer decisions vary widely.

Prior Authorization Requirements

When a Kentucky commercial plan does cover vardenafil, prior authorization is common. Typical PA criteria require documentation of an ED diagnosis (ICD-10 code N52.x), a clinician attestation that the patient has no contraindications (particularly nitrate use), and sometimes a trial of sildenafil first. Collecting these documents before submitting the PA request speeds approval.

Telehealth Prescribing of Vardenafil in Kentucky

Kentucky permits telehealth prescribing of vardenafil by licensed Kentucky physicians, nurse practitioners, and physician assistants operating within their scope of practice. The prescriber must conduct a clinically appropriate evaluation before issuing a controlled-substance-adjacent prescription, though vardenafil itself is not a scheduled controlled substance.

What a Telehealth Visit Should Include

A responsible telehealth prescriber will review cardiovascular history before prescribing any PDE5 inhibitor. Vardenafil is contraindicated with all organic nitrates and with alpha-blockers at doses that could cause hypotension. The FDA label for vardenafil states that co-administration with nitrates "could result in potentially life-threatening hypotension". A telehealth visit that skips cardiovascular screening is a clinical red flag.

The prescriber should also note that vardenafil prolongs the QTc interval at higher doses. Patients on Class IA or Class III antiarrhythmics should not take vardenafil, per the FDA label.

Kentucky Telehealth Law

Kentucky's telehealth statute (KRS 211.332 et seq.) allows audio-visual visits to establish a valid patient-physician relationship, which is required before prescribing. Audio-only visits may be insufficient to establish that relationship for new patients seeking a new prescription. Patients should ensure their telehealth encounter is conducted via video.

Clinical Efficacy: What the Evidence Shows

Vardenafil's efficacy for erectile dysfunction is well-established across multiple randomized controlled trials. Understanding the evidence helps patients set realistic expectations about what the drug can and cannot do.

The Porst et al. 2003 Trial

Porst and colleagues published a key multicenter, randomized, double-blind, placebo-controlled trial of vardenafil in men with erectile dysfunction across a broad severity range. Porst H et al. (Int J Impot Res 2003) demonstrated that vardenafil 10 mg and 20 mg produced statistically significant improvements in erectile function domain scores versus placebo (P<0.001). Successful intercourse rates reached 65 to 80% on active drug compared with 30% on placebo in that trial.

The drug's half-life of approximately 4 to 5 hours means the erection-facilitating window is shorter than tadalafil (Cialis), which has a 17.5-hour half-life. For on-demand use, vardenafil's 30 to 60 minute pre-activity dosing window works well for most patients.

Onset and Duration

Vardenafil reaches maximum plasma concentration (Tmax) in approximately 30 to 120 minutes, with food (particularly high-fat meals) delaying absorption. Pharmacokinetic data from the FDA label confirm Tmax of 0.5 to 2 hours in fasted state. Patients who take the drug with a large steak dinner before a date may experience slower onset.

Vardenafil vs. Sildenafil: Is One Cheaper in Kentucky?

Generic sildenafil (Viagra's generic) is often priced even lower than generic vardenafil in Kentucky, with some GoodRx prices for sildenafil 100 mg running below $1.00 per tablet at certain pharmacies. Patients whose prescribers are open to either agent should compare real-time pricing at their preferred pharmacy before filling. FDA-approved generic sildenafil products are listed in the Orange Book. The clinical choice between agents should be driven by individual tolerability and the prescriber's clinical judgment, not price alone, but price is a legitimate factor to discuss.

Discount Programs and Savings Cards for Vardenafil in Kentucky

Several programs can reduce out-of-pocket costs for Kentucky patients who pay cash.

GoodRx and Similar Platforms

GoodRx, RxSaver, and Blink Health aggregate pharmacy pricing and negotiate discount rates. In Kentucky, GoodRx-listed prices for generic vardenafil 10 mg (30 tablets) at major chains range from approximately $60 to $130, depending on the pharmacy. These prices are not insurance; they are negotiated discount rates that cannot be combined with insurance in most cases.

Bayer Patient Assistance

Bayer operates a patient assistance program for Levitra through its US Medical Needs program. Income-eligible patients who are uninsured or underinsured may qualify for free or reduced-cost brand Levitra. Bayer's patient assistance information is coordinated through NeedyMeds, which aggregates manufacturer programs. Kentucky patients can search by drug name to find current eligibility criteria.

HealthRX Telehealth Pricing

HealthRX's internal prescribing data from Kentucky patients in 2025 show that patients who obtained vardenafil through the HealthRX telehealth platform and a partnered 503A compounding pharmacy paid a median of $58 per month, inclusive of the consultation fee, compared with a median of $114 per month at retail for generic vardenafil. That represents a 49% reduction versus the Kentucky retail average.

Practical Guidance for Kentucky Patients

Patients in Kentucky who want vardenafil at the lowest reasonable cost and with the fewest delays should follow a straightforward path.

Step 1: Confirm You Are a Candidate

Vardenafil is contraindicated if you take any nitrate medication (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite). It requires caution in patients with a recent stroke or myocardial infarction (within 6 months), resting hypotension (BP <90/50 mmHg), or inherited QT prolongation. The FDA label specifies these contraindications in full.

Tell your prescriber about every medication you take. Drug interactions with CYP3A4 inhibitors (ritonavir, ketoconazole, erythromycin) can increase vardenafil plasma levels significantly, requiring dose reductions.

Step 2: Get a Prescription via Telehealth or In-Person

Either route is valid in Kentucky. Telehealth saves a clinic visit for patients in rural areas (eastern or western Kentucky where urology access is limited). Confirm the prescriber is licensed in Kentucky.

Step 3: Compare Pharmacy Prices Before Filling

Use GoodRx or a similar tool to compare prices at your nearest pharmacies before you hand over the prescription. Prices at the same chain can vary by $30, $40 between zip codes. Prices at independent pharmacies sometimes beat chain prices by 10 to 20%.

Step 4: Ask About 503A Compounding

If your prescriber and a licensed 503A pharmacy agree you are a candidate, compounded vardenafil may be your lowest-cost option. Verify the pharmacy's Kentucky license status at the Kentucky Board of Pharmacy license lookup.